drugset / Trial / NCT00337922

Pharmacokinetic Study Of EPZICOM Tablet

NCT00337922

Phase 4 Completed 8 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was designed to explore the drug levels in the blood in Japanese HIV-infected patients taking EPZICOM tablet at least for 2 weeks prior to administration of the study drug. Pharmacokinetics after administration of EPZICOM tablet will be investigated in a total of 8 subjects.

Timeline

Start
2006-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified
Subject Lamivudine Other / unclassified